Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ohno

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Hematology|February 8, 2008
Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocolMoe Wakui, Kazutaka Kuriyama, Yasushi Miyazaki, et al.
International Journal of Hematology|June 29, 2004
Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemiaKazunori Ohnishi, Akio Ino, Yuji Kishimoto, et al.
Journal of Gastroenterology|August 5, 2003
Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumorAkira Sawaki, Kazuhiko Ohashi, Kenji Yamao, et al.
Cancer Letters|August 18, 2004
Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemiasKazuyuki Shigeno, Hitoshi Yoshida, Ling Pan, et al.
Cancer Genetics and Cytogenetics|June 15, 2004
Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemiaAkihiro Takeshita, Kensuke Naito, Kaori Shinjo, et al.
International Journal of Hematology|January 5, 2010
Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study GroupYasuyoshi Morita, Akihisa Kanamaru, Yasushi Miyazaki, et al.
British Journal of Haematology|June 13, 2002
Clinicopathological and prognostic characteristics of CD56-negative multiple myelomaNaohi Sahara, Akihiro Takeshita, Kazuyuki Shigeno, et al.
British Journal of Haematology|December 21, 2002
Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 studyYasushi Miyazaki, Kazutaka Kuriyama, Shuichi Miyawaki, et al.
International Journal of Hematology|December 7, 2007
Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG)Shuichi Miyawaki, Yasukazu Kawai, Akihiro Takeshita, et al.
International Journal of Hematology|January 30, 2010
The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0Ritsuro Suzuki, Shigeki Ohtake, Jin Takeuchi, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Hematology|February 8, 2008
Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocolMoe Wakui, Kazutaka Kuriyama, Yasushi Miyazaki, et al.
International Journal of Hematology|June 29, 2004
Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemiaKazunori Ohnishi, Akio Ino, Yuji Kishimoto, et al.
Journal of Gastroenterology|August 5, 2003
Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumorAkira Sawaki, Kazuhiko Ohashi, Kenji Yamao, et al.
Cancer Letters|August 18, 2004
Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemiasKazuyuki Shigeno, Hitoshi Yoshida, Ling Pan, et al.
Cancer Genetics and Cytogenetics|June 15, 2004
Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemiaAkihiro Takeshita, Kensuke Naito, Kaori Shinjo, et al.
International Journal of Hematology|January 5, 2010
Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study GroupYasuyoshi Morita, Akihisa Kanamaru, Yasushi Miyazaki, et al.
British Journal of Haematology|June 13, 2002
Clinicopathological and prognostic characteristics of CD56-negative multiple myelomaNaohi Sahara, Akihiro Takeshita, Kazuyuki Shigeno, et al.
British Journal of Haematology|December 21, 2002
Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 studyYasushi Miyazaki, Kazutaka Kuriyama, Shuichi Miyawaki, et al.
International Journal of Hematology|December 7, 2007
Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG)Shuichi Miyawaki, Yasukazu Kawai, Akihiro Takeshita, et al.
International Journal of Hematology|January 30, 2010
The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0Ritsuro Suzuki, Shigeki Ohtake, Jin Takeuchi, et al.
Pageof 8